Search research articles
Contact Us
Filters
Showing results (411-420 of 423) with videos related to
Page
of 43
Sort By:
Nature Communications
|
March 4, 2024
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma
Xing Cheng, Jing An, Jitong Lou, et al.
National Science Review
|
January 29, 2026
Single-crystal orientation lithium for ultra-stable all-solid-state batteries
Qidong Li, Likun Chen, Junyu Jiao, et al.
Iscience
|
August 21, 2025
Innexin DNA-binding domains regulate <i>Microplitis bicoloratus</i> bracoviral transcription in symbiotic wasps
Hong-Mei Tang, Qiong-Li Zhang, Xin Qiao, et al.
Frontiers in Immunology
|
December 26, 2023
Simulating immunosuppressive mechanism of <i>Microplitis bicoloratus bracovirus</i> coordinately fights <i>Spodoptera frugiperda</i>
Xing-Cheng Li, Yin-Chen Ma, Jin Long, et al.
NPJ Vaccines
|
July 29, 2022
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
Mariana F Tioni, Robert Jordan, Angie Silva Pena, et al.
Nature
|
October 30, 2025
A ductile solid electrolyte interphase for solid-state batteries
Jinshuo Mi, Jun Yang, Likun Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 10, 2020
Optimization of globomycin analogs as novel gram-negative antibiotics
Keira Garland, Homer Pantua, Marie-Gabrielle Braun, et al.
Iscience
|
April 5, 2024
Innexin hemichannel activation by <i>Microplitis bicoloratus</i> ecSOD monopolymer reduces ROS
Jiang-Hui Meng, Yong-Biao Huang, Jin Long, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2019
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling
Mark Zak, Emily J Hanan, Patrick Lupardus, et al.
Science Bulletin
|
September 24, 2023
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial
Yue-Mei Hu, Zhao-Feng Bi, Ya Zheng, et al.
Page
of 43
Search research articles
Search
Showing results (411-420 of 423) with videos related to
Sort By:
Page
of 43
Nature Communications
|
March 4, 2024
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma
Xing Cheng, Jing An, Jitong Lou, et al.
National Science Review
|
January 29, 2026
Single-crystal orientation lithium for ultra-stable all-solid-state batteries
Qidong Li, Likun Chen, Junyu Jiao, et al.
Iscience
|
August 21, 2025
Innexin DNA-binding domains regulate <i>Microplitis bicoloratus</i> bracoviral transcription in symbiotic wasps
Hong-Mei Tang, Qiong-Li Zhang, Xin Qiao, et al.
Frontiers in Immunology
|
December 26, 2023
Simulating immunosuppressive mechanism of <i>Microplitis bicoloratus bracovirus</i> coordinately fights <i>Spodoptera frugiperda</i>
Xing-Cheng Li, Yin-Chen Ma, Jin Long, et al.
NPJ Vaccines
|
July 29, 2022
Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
Mariana F Tioni, Robert Jordan, Angie Silva Pena, et al.
Nature
|
October 30, 2025
A ductile solid electrolyte interphase for solid-state batteries
Jinshuo Mi, Jun Yang, Likun Chen, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 10, 2020
Optimization of globomycin analogs as novel gram-negative antibiotics
Keira Garland, Homer Pantua, Marie-Gabrielle Braun, et al.
Iscience
|
April 5, 2024
Innexin hemichannel activation by <i>Microplitis bicoloratus</i> ecSOD monopolymer reduces ROS
Jiang-Hui Meng, Yong-Biao Huang, Jin Long, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 15, 2019
Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling
Mark Zak, Emily J Hanan, Patrick Lupardus, et al.
Science Bulletin
|
September 24, 2023
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial
Yue-Mei Hu, Zhao-Feng Bi, Ya Zheng, et al.
Page
of 43